Annex Advisory Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.6M Buy
3,835
+60
+2% +$61.3K 0.08% 108
2026
Q1
$3.47M Sell
3,775
-229
-6% -$232K 0.07% 124
2025
Q4
$4.3M Buy
4,004
+57
+1% +$54.5K 0.08% 114
2025
Q3
$3.01M Buy
3,947
+20
+0.5% +$14.9K 0.06% 115
2025
Q2
$3.06M Sell
3,927
-197
-5% -$153K 0.07% 113
2025
Q1
$3.41M Buy
4,124
+240
+6% +$200K 0.1% 98
2024
Q4
$3M Sell
3,884
-337
-8% -$279K 0.09% 101
2024
Q3
$3.74M Sell
4,221
-182
-4% -$164K 0.12% 93
2024
Q2
$3.99M Buy
4,403
+71
+2% +$56.8K 0.14% 88
2024
Q1
$3.37M Buy
4,332
+535
+14% +$381K 0.12% 93
2023
Q4
$2.21M Buy
3,797
+1,547
+69% +$903K 0.09% 100
2023
Q3
$1.21M Buy
2,250
+12
+0.5% +$6.18K 0.07% 100
2023
Q2
$1.05M Sell
2,238
-12
-0.5% -$5.03K 0.06% 106
2023
Q1
$773K Sell
2,250
-8
-0.4% -$2.7K 0.04% 121
2022
Q4
$826K Sell
2,258
-665
-23% -$236K 0.05% 125
2022
Q3
$945K Buy
2,923
+7
+0.2% +$2.22K 0.06% 121
2022
Q2
$946K Buy
2,916
+513
+21% +$154K 0.07% 132
2022
Q1
$688K Buy
2,403
+82
+4% +$21.1K 0.05% 137
2021
Q4
$641K Buy
2,321
+444
+24% +$113K 0.04% 142
2021
Q3
$434K Sell
1,877
-321
-15% -$79.2K 0.04% 149
2021
Q2
$504K Buy
2,198
+73
+3% +$14.7K 0.04% 145
2021
Q1
$397K Buy
2,125
+27
+1% +$5.28K 0.04% 143
2020
Q4
$354K Buy
2,098
+16
+0.8% +$2.39K 0.03% 143
2020
Q3
$308K Buy
2,082
+3
+0.1% +$464 0.04% 101
2020
Q2
$341K Buy
2,079
+2
+0.1% +$307 0.05% 99
2020
Q1
$288K Buy
2,077
+18
+0.9% +$2.47K 0.04% 103
2019
Q4
$271K Sell
2,059
-57
-3% -$6.61K 0.03% 109
2019
Q3
$236K Buy
+2,116
New +$236K 0.03% 116
2019
Q2
Sell
-1,546
Closed -$201K 124
2019
Q1
$201K Buy
+1,546
New +$188K 0.03% 122

Other funds holding LLY

Annex Advisory Services's LLY Position: Q2 2026 in Review

Annex Advisory Services increased its Eli Lilly (LLY) stake by 1.6% in Q2 2026, buying an estimated $61.3K and bringing the position to 3,835 shares worth $4.6M. The position accounts for 0.08% of the portfolio, ranked #108.

Annex Advisory Services first reported a position in LLY in Q1 2019 and has held it in 29 quarters since. 990 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Annex Advisory Services held 3,835 shares of Eli Lilly worth $4.6M as of Q2 2026.
  • Annex Advisory Services bought 60 Eli Lilly shares in Q2 2026, an estimated $61.3K.
  • Eli Lilly made up 0.08% of Annex Advisory Services's portfolio in Q2 2026, its #108 holding.
  • Annex Advisory Services first reported a position in Eli Lilly in Q1 2019 and has held it in 29 quarters since.
  • 990 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Annex Advisory Services's 13F filing for Q2 2026, filed 10 Jul 2026.